Gain Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Gain Therapeutics

23/03/2023 21:08

* Gain Therapeutics Inc  GANX.OQ  reported a quarterly
adjusted
loss of 39 cents​​ per share for the quarter ended in December.
The mean expectation of four analysts for the quarter was for a
loss of 38 cents per share.
    * Reported revenue was zero​; analysts expected $12.50
thousand. 
    * Gain Therapeutics Inc's reported EPS for the quarter was a
loss
of 39 cents​.
    * The mean earnings estimate of analysts had fallen by
about 10.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Gain Therapeutics Inc shares had risen by 56.9% this
quarter.
    * The company reported a quarterly loss of $4.68 million.
    * Wall Street's median 12-month price target for Gain
Therapeutics
Inc is $10.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 23 at 09:07 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.38          -0.39          Missed
 Sep. 30 2022      -0.46          -0.38          Beat
 Jun. 30 2022      -0.31          -0.43          Missed
 Mar. 31 2022      -0.37          -0.28          Beat